What makes it the right choice
BPC-157 and TB-500 Dosage Protocol BPC-157: 250500mcg daily, injected subcutaneously near the injury site TB-500: 22.5mg twice weekly (loading phase) for 46 weeks, then 2mg once weekly (maintenance phase) The combination is typically used for 612 weeks, depending on injury severity and healing progress
The biggest one is stacked GI side effects - nausea, vomiting, diarrhea, and constipation - because both compounds slow digestion
MIC is the methionine/inositol/choline base
In September 2023, the FDA classified BPC-157 as a Category 2 bulk drug substance under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act
W leczeniu zapobiegawczym za pomoc terapii BPC-157 prowadzi do zmniejszenia ryzyka powstawania zwenia moczowodu w przyszoci